ARK Invest backs the factories behind automated cell therapies

Cathie Wood’s firm joins Cellares’ $277m funding round as investors bet manufacturing not discovery will determine future of cell therapy. Cell therapy has produced remarkable results. Researchers have learned how to engineer immune cells to hunt down cancer, and new therapies are showing potential in autoimmune diseases that have long resisted conventional treatment. Yet despite […] The post ARK Invest backs the factories behind automated cell therapies appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.